LATE LAST MONTH, Myriad Genetics Inc. announced a definitive agreement to acquire Counsyl, Inc., an innovative genetic testing company in South San Francisco, Calif., for $375 million. In a deal that is expected to close by early next year, Myriad will use a combination of cash and common stock. Founded in 2007, Counsyl offers carrier […]
- Lab Acquisitions Update
Myriad to Buy Counsyl, to Gain Presence in NIPS Test Sector
In women’s health testing market, Myriad Genetics will have a commanding presence
- By Joseph Burns
- > From the Volume XXV No. 9 - June 18, 2018 Issue
